Jennison Associates
North America, New York, United States, New York
Description
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.
Investor Profile
Jennison Associates has backed more than 27 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 26 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, France.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (26%)
- Post Ipo Equity (22%)
- Series C (15%)
- Series D (11%)
- Series Unknown (7%)
- Private Equity (7%)
- Convertible Note (4%)
- Series F (4%)
- Series E (4%)
Country Focus
- United States (93%)
- Canada (4%)
- France (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Genetics
- Biopharma
- Health Diagnostics
- Medical Device
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Jennison Associates frequently co-invest with?
Which angels does Jennison Associates often collaborate with?
What are some of recent deals done by Jennison Associates?
Find More Investors Like Jennison Associates
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
